VIRI Provides Overview of Phase 3 Program in Fibromyalgia
VIRIDelisted Stock | USD 3.95 0.00 0.00% |
Under 55% of Virios Therapeutics' investor base is interested to short. The analysis of current outlook of investing in Virios Therapeutics Llc suggests that many traders are impartial regarding Virios Therapeutics' prospects. Virios Therapeutics' investing sentiment shows overall attitude of investors towards Virios Therapeutics Llc.
Virios |
By David Bautz, PhD NASDAQVIRI READ THE FULL VIRI RESEARCH REPORT Business Update Overview of Phase 3 Program for IMC-1 in Fibromyalgia Virios Therapeutics, Inc. is developing IMC-1 as a therapy for fibromyalgia . The company previously reported results from the Phase 2b FORTRESS trial in September 2022. Topline results showed that the
Read at finance.yahoo.com
Virios Therapeutics Fundamental Analysis
We analyze Virios Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Virios Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Virios Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Market Capitalization
Market Capitalization Comparative Analysis
Virios Therapeutics is currently under evaluation in market capitalization category among its peers. Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Virios Therapeutics Llc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Virios Therapeutics stock to make a market-neutral strategy. Peer analysis of Virios Therapeutics could also be used in its relative valuation, which is a method of valuing Virios Therapeutics by comparing valuation metrics with similar companies.
Peers
Virios Therapeutics Related Equities
CYTO | Altamira Therapeutics | 7.50 | ||||
IMMX | Immix Biopharma | 7.11 | ||||
PHIO | Phio Pharmaceuticals | 3.03 | ||||
RNAZ | Transcode Therapeutics | 2.94 | ||||
ZURA | Zura Bio | 1.67 | ||||
REVB | Revelation Biosciences | 1.33 | ||||
ICU | LMF Acquisition | 1.57 | ||||
SONN | Sonnet Biotherapeutics | 2.28 | ||||
ZVSA | ZyVersa Therapeutics | 3.60 | ||||
CNSP | Cns Pharmaceuticals | 8.33 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Consideration for investing in Virios Stock
If you are still planning to invest in Virios Therapeutics Llc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Virios Therapeutics' history and understand the potential risks before investing.
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Stocks Directory Find actively traded stocks across global markets | |
Transaction History View history of all your transactions and understand their impact on performance | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance |